Pharmacology of the central nervous system.
D000435:Alcoholic Intoxication; D000777:Anesthetics / Q000494:pharmacology; D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology; D000928:Antidepressive Agents / Q000627:therapeutic use; D001519:Behavior / Q000187:drug effects; D002490:Central Nervous System / Q000187:drug effects* / Q000378:metabolism / Q000502:physiology; D000697:Central Nervous System Stimulants / Q000494:pharmacology; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use; D004195:Disease Models, Animal; D004361:Drug Tolerance; D006213:Hallucinogens / Q000494:pharmacology; D006728:Hormones / Q000494:pharmacology; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D018377:Neurotransmitter Agents / Q000502:physiology; D010300:Parkinson Disease / Q000188:drug therapy; D010455:Peptides / Q000494:pharmacology; D051381:Rats; D019966:Substance-Related Disorders; D014149:Tranquilizing Agents / Q000009:adverse effects / Q000627:therapeutic use / Q000633:toxicity
D000777:Anesthetics; D000927:Anticonvulsants; D000928:Antidepressive Agents; D000697:Central Nervous System Stimulants; D006213:Hallucinogens; D006728:Hormones; D006993:Hypnotics and Sedatives; D008996:Monoamine Oxidase Inhibitors; D018377:Neurotransmitter Agents; D010455:Peptides; D014149:Tranquilizing Agents; D004295:Dihydroxyphenylalanine